Anne-marie M. Jansen-Cleton

Leiden, ZH, Netherlands

Last Updated: 09/26/2026

Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 87 publications

Accurate Prediction of Central Conventional Chondrosarcoma Risk and Outcome Using Methylation Profiling: CHROME.

Accurate Prediction of Central Conventional Chondrosarcoma Risk and Outcome Using Methylation Profiling: CHROME.

Journal: Genes, chromosomes & cancer
Published: May 29, 2026

Osteosarcoma 3D patient derived cultures to test genome-informed personalized treatment options: a feasibility study.

Osteosarcoma 3D patient derived cultures to test genome-informed personalized treatment options: a feasibility study.

Journal: Frontiers in medicine
Published: November 25, 2025

Molecular Analysis in Salivary Gland Tumors: Exploring the Diagnostic and Clinical Impact of Comprehensive Next Generation RNA Sequencing ("SalvGlandDx v2").

Molecular Analysis in Salivary Gland Tumors: Exploring the Diagnostic and Clinical Impact of Comprehensive Next Generation RNA Sequencing ("SalvGlandDx v2").

Journal: Head and neck pathology
Published: September 29, 2025

Recurrent MDM2 Amplification in the Spectrum of HMGA2-Altered Pleomorphic Adenoma, Atypical Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma.

Recurrent MDM2 Amplification in the Spectrum of HMGA2-Altered Pleomorphic Adenoma, Atypical Pleomorphic Adenoma and Carcinoma Ex Pleomorphic Adenoma.

Journal: Head and neck pathology
Published: February 02, 2025

Truncated FOS impairs osteogenic differentiation and induces prostaglandin and NFκB signalling in an in vitro cell-of-origin model for osteoid osteoma and osteoblastoma.

Truncated FOS impairs osteogenic differentiation and induces prostaglandin and NFκB signalling in an in vitro cell-of-origin model for osteoid osteoma and osteoblastoma.

Journal: The Journal of pathology
Published: January 21, 2025

Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours.

Clinical outcomes and genomic profiles of MAP2K1-mutated primary cutaneous melanocytic tumours.

Journal: EBioMedicine
Published: November 07, 2024

The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS Analysis.

The Variable Genomic Landscape During Osteosarcoma Progression: Insights From a Longitudinal WGS Analysis.

Journal: Genes, chromosomes & cancer
Published: May 14, 2024

Formalin-Fixed, Paraffin-Embedded-Targeted Locus Capture: A Next-Generation Sequencing Technology for Accurate DNA-Based Gene Fusion Detection in Bone and Soft Tissue Tumors.

Formalin-Fixed, Paraffin-Embedded-Targeted Locus Capture: A Next-Generation Sequencing Technology for Accurate DNA-Based Gene Fusion Detection in Bone and Soft Tissue Tumors.

Journal: The Journal of molecular diagnostics : JMD
Published: February 28, 2023

No NFATC2 fusion in simple bone cyst of the jaw.

No NFATC2 fusion in simple bone cyst of the jaw.

Journal: Histopathology
Published: December 21, 2022

SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin.

SLC7A8 coding for LAT2 is associated with early disease progression in osteosarcoma and transports doxorubicin.

Journal: Frontiers in pharmacology
Published: September 13, 2022

Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia.

Genome-wide analyses of platinum-induced ototoxicity in childhood cancer patients: Results of GO-CAT and United Kingdom MAGIC consortia.

Journal: Frontiers in pharmacology
Published: June 28, 2022

The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis.

The sensitivity of pan-TRK immunohistochemistry in solid tumours: A meta-analysis.

Journal: European journal of cancer (Oxford, England : 1990)
Published: October 15, 2021
Showing 1-12 of 87

Last Updated: 09/26/2026